Fig. 1From: Representativeness of European clinical trial populations in mild Alzheimer’s disease dementia: a comparison of 18-month outcomes with real-world data from the GERAS observational studyStandardised differences (between EU EXPEDITION and GERAS patients) for baseline characteristics before and after propensity score adjustment. AChEI acetylcholinesterase inhibitor, MMSE Mini-Mental State ExaminationBack to article page